Concepedia

Andrew J. Kocab

AJ

Statistics

Publications

4

Citations

237

H-Index

4

Active since

2009

Affiliations

University of Michigan(Current)

ONL Therapeutic (United States)

Andrew J. Kocab is an author at University of Michigan specializing in medicine, pharmacology, and cell signaling.

ORCID

Top concepts

Publications per year

2009–2024

4

Publications

4

A small peptide antagonist of the Fas receptor inhibits neuroinflammation and prevents axon degeneration and retinal ganglion cell death in an inducible mouse model of glaucoma

Anitha Krishnan, Andrew J. Kocab, David N. Zacks et al. · Journal of Neuroinflammation · 2019 · 132 citations · Full text

Design, synthesis and prostate cancer cell-based studies of analogs of the Rho/MKL1 transcriptional pathway inhibitor, CCG-1423

Chris R. Evelyn, Jessica L. Bell, Jenny G. Ryu et al. · Bioorganic & Medicinal Chemistry Letters · 2009 · 66 citations · Full text

, , +6

Copper is a potent inhibitor of both the canonical and non-canonical NFκB pathways

Niall S. Kenneth, George Hucks, Andrew J. Kocab et al. · Cell Cycle · 2014 · 27 citations · Full text

, , +21

Preservation of retinal structure and function in two mouse models of inherited retinal degeneration by ONL1204, an inhibitor of the Fas receptor

Meng-Ling Yang, Jingyu Yao, Lin Jia et al. · Cell Death and Disease · 2024 · 12 citations · Full text

1–4 of 4